Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
History of genetic engineering wikipedia , lookup
Public health genomics wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Designer baby wikipedia , lookup
Heritability of IQ wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Research Review No. 95. Tadalafil Amelioration of Duchenne Muscular Dystrophy The Studies: The authors of the publication (1) from Rome, Italy, examined the effects of treating mdx mice, i.e. mice having a mutation in their dystrophin gene, which are used as a model for Duchenne Muscular Dystrophy (DMD), with tadalafil. Due to the adverse side effects that corticosteroids, which are currently the drugs of choice for ameliorating DMD, can have on patients, the authors investigated the effect of different types of non-steroidal anti-inflammatory drugs (NSAIDs) on mdx mice. A study reported in 2012 “revealed that these compounds have a beneficial effect on dystrophic muscle morphology that is comparable to glucocorticoid treatment”. As a result of extensive biochemical and physiological studies, the authors concluded that agents which affected a family of enzymes called phosphodiesterases (PDEs), which are “extensively used in human therapy, and much is known regarding their toxicology, potential side effects, drug regimens, and pharmacoepidemiology, as well as regarding tolerance to their long-term use. PDE5 plays a critical role in heart physiology”. It had been observed in earlier studies that “following PDE5 inhibition, an improvement of vascular activity in dystrophic mice and a reduction of skeletal myofibril damage were observed”. The authors therefore investigated the molecular alterations that could possibly contribute to the therapeutic effects of drugs blocking PDE5 on mdx mice. The results of these studies are well presented especially in the colourful graphs, which show that mdx mice treated with tadalafil work on the treadmill nearly as well as wild-type mice. Also they note that “more than 200 genes are up-regulated and approximately 140 genes are downregulated in dystrophic muscles following tadalafil treatment.” These are the first studies that reveal “critical pathways implicated in tadalafil-based therapy in muscular dystrophy”, they also show most importantly, that “tadalafil can compensate the loss of functional dystrophin in muscle cells by metabolic reprogramming of myofibers towards a profile more resistant to contraction-induced damage”. This beneficial effect is explained by detailed biochemistry of the role of tadalafil. References: 1) De Arcangelis, V., Strimpakos, G., Gabanella, F., Corbi, N., Luvisetto, S., Magrelli, A., Onori, A., Passananti, C., Pisani, C., Rome, S., Severini, C., Naro, F., Mattei, E., Di Certo, M.G. & Monaco, L. (2016) Pathways Implicated in Tadalafil Amelioration of Duchenne Muscular Dystrophy. Journal of Cellular Physiology. 231(1):224-232. 2) Serra, F., Quarta, M., Canato, M., Toniolo, L., De Arcangelis, V,., Trotta, A., Spath, L., Monaco, L., Reggiani, C. & Naro, F. (2012) Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle and Nerve. 46:773–784. Karl A. Bettelheim 23.10.2015